Series A - AmacaThera

Series A - AmacaThera

Investment Firm

Overview

AmacaThera's injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes.

Announced Date

Feb 22, 2021

Closed on Date

Feb 22, 2021

Funding Type

Series A

Highlights

Location

North America

Social

Investor Lead

N/A

Participant Investors

7

Investor Name
Participant InvestorBDC Capital’s Women in Technology Venture Fund
Participant InvestorMBX Capital
Participant InvestorStandUp Ventures
Participant InvestorInveready
Participant InvestorMaRS Investment Accelerator Fund

Round Details and Background

AmacaThera raised $10300000 on 2021-02-22 in Series A

AmacaThera's injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 22, 2021
Series A - AmacaThera
9-10.3M
Jan 04, 2023
Grant - AmacaThera
1-undefined
Nov 28, 2023
Series A - AmacaThera
6-2.9M
Dec 01, 2023
Grant - AmacaThera
1-50.0K